Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
37.90
+1.70 (4.70%)
At close: Jun 26, 2026, 4:00 PM EDT
37.15
-0.75 (-1.98%)
After-hours: Jun 26, 2026, 7:57 PM EDT
Agios Pharmaceuticals Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Agios Pharmaceuticals stock have an average target of 38.38, with a low estimate of 28 and a high estimate of 54. The average target predicts an increase of 1.27% from the current stock price of 37.90.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Agios Pharmaceuticals stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 16, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $32 | Hold | Maintains | $32 | -15.57% | Jun 15, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $36 | Buy | Maintains | $36 | -5.01% | Jun 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $54 | Buy | Reiterates | $54 | +42.48% | Jun 15, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $40 | Buy | Maintains | $40 | +5.54% | Jun 15, 2026 |
Financial Forecast
Revenue This Year
121.91M
from 54.03M
Increased by 125.65%
Revenue Next Year
256.79M
from 121.91M
Increased by 110.63%
EPS This Year
-6.18
from -7.12
EPS Next Year
-4.72
from -6.18
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 165.7M | 355.3M | |
| Avg | 121.9M | 256.8M | |
| Low | 88.8M | 130.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 206.6% | 191.5% | |
| Avg | 125.6% | 110.6% | |
| Low | 64.4% | 6.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -5.50 | -3.84 | |
| Avg | -6.18 | -4.72 | |
| Low | -7.21 | -6.16 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.